Yahoo Finance • 13 hours ago
Key Points Two gene-editing companies are advancing therapies, with one generating commercial sales and both approaching major regulatory milestones. An AI drug discovery company is approaching multiple trial readouts in late 2025 that co... Full story
Yahoo Finance • 3 days ago
If you're holding shares of Vertex Pharmaceuticals or thinking about adding some to your portfolio, you're not alone in wondering what the right move is. The stock's recent momentum may have caught your eye. Over just the past week, Vertex... Full story
Yahoo Finance • 7 days ago
ClearBridge Investments, an investment management company, released its “ClearBridge Large Cap Growth Strategy” third-quarter 2025 investor letter. A copy of the letter can be downloaded here. Equities continued their upward journey in the... Full story
Yahoo Finance • 9 days ago
Key Points The announcement of another strategic partnership in the data center space confirms that spending on AI and data centers is much more than a passing trend. Vertiv's data center infrastructure solutions make it ideally placed to... Full story
Yahoo Finance • 13 days ago
Atlantic City, Sept. 30, 2025 (GLOBE NEWSWIRE) -- The first-ever NJ Healthy Aging Summit, convened by the Partnership for a Drug-Free New Jersey (PDFNJ) in partnership with the New Jersey Division of Mental Health and Addiction Services... Full story
Yahoo Finance • 15 days ago
With the first three quarters of the calendar year in the books, investors are strolling into October with the major indexes at all-time highs and a more than 20% year-to-date gain in the S&P 500 and Nasdaq Composite. Go back even further,... Full story
Yahoo Finance • 16 days ago
Vertex Pharmaceuticals recently announced that the FDA has granted Breakthrough Therapy Designation to povetacicept for IgA nephropathy, along with key clinical advancements in its kidney disease pipeline. This regulatory milestone may hel... Full story
Yahoo Finance • 16 days ago
Below is Validea's guru fundamental report for VERTEX PHARMACEUTICALS INCORPORATED (VRTX). Of the 22 guru strategies we follow, VRTX rates highest using our Twin Momentum Investor model based on the published strategy of Dashan Huang. Thi... Full story
Yahoo Finance • 17 days ago
Below is Validea's guru fundamental report for VERTEX PHARMACEUTICALS INC (VRTX). Of the 22 guru strategies we follow, VRTX rates highest using our P/B Growth Investor model based on the published strategy of Partha Mohanram. This growth... Full story
Yahoo Finance • 19 days ago
What Happened? Shares of data center products and services company Vertiv (NYSE:VRT) fell 6.2% in the afternoon session after Microsoft announced it had successfully tested a new microfluidic cooling system for data center chips, posing a... Full story
Yahoo Finance • 19 days ago
Investing.com -- Vertiv Holdings Co. (NYSE: VRT) shares fell 7% Tuesday after Microsoft (NASDAQ: MSFT) announced the successful testing of a new microfluidic cooling system for data center chips that could potentially disrupt the thermal m... Full story
Yahoo Finance • 23 days ago
Key Points It is a good time to invest in healthcare stocks. Investors should look into Pfizer and Vertex Pharmaceuticals. Pfizer's financial results and pipeline have improved, which should allow it to overcome upcoming headwinds. Vertex... Full story
Yahoo Finance • 25 days ago
[Business on Wall Street in Manhattan] Pgiam/iStock via Getty Images CRISPR Therapeutics (NASDAQ:CRSP [https://seekingalpha.com/symbol/CRSP]) traded higher in the premarket on Thursday after J.P. Morgan initiated its coverage with an Over... Full story
Yahoo Finance • 27 days ago
NEW YORK, Sept. 15, 2025 /PRNewswire/ -- Fred Alger Management, LLC ("Alger"), a privately held growth equity investment manager, today announced the quarterly rebalancing of the Alger Russell Innovation Index ("Index"). Following the clos... Full story
Yahoo Finance • 28 days ago
Below is Validea's guru fundamental report for VERTEX PHARMACEUTICALS INCORPORATED (VRTX). Of the 22 guru strategies we follow, VRTX rates highest using our Twin Momentum Investor model based on the published strategy of Dashan Huang. Thi... Full story
Yahoo Finance • 28 days ago
VANCOUVER, British Columbia, Sept. 15, 2025 (GLOBE NEWSWIRE) -- Vortex Energy Corp. (CSE: VRTX) (OTC: VTECF) (FSE: AA3) (“Vortex” or the “Company”) is pleased to announce the successful completion of the field component of its Ambient No... Full story
Yahoo Finance • 28 days ago
Key Points The company's book-to-bill ratio suggests significant future growth. The AI/data center capital spending market may well be only in its early innings. 10 stocks we like better than Vertiv › It's no secret that the AI/data cent... Full story
Yahoo Finance • last month
Key Points A major new deal in the industry confirmed that the lights are all green for the data center infrastructure market. The company is preparing for another surge in growth in the coming years, with the introduction of new data cen... Full story
Yahoo Finance • last month
VERTEX PHARMACEUTICALS INC (NASDAQ:VRTX [https://www.chartmill.com/stock/quote/VRTX]) has appeared as a notable candidate from a screening method that mixes firm fundamental growth measures with encouraging technical breakout formations. T... Full story
Yahoo Finance • last month
Company Logo The United States Cystic Fibrosis Therapeutics Market is set to grow from an estimated US$ 2.32 billion in 2024 to US$ 4.72 billion by 2033, with an 8.22% CAGR from 2025 to 2033. This growth is driven by advancements in gene... Full story